A consecutive series of 1100 patients was identified.

In one series of 59 patients, mortality amounted to 5%.

This study presents our findings in a series of 25 consecutive patients.

Gradually a series of 29 patients were treated and documented.

Note that for the study involved in the above table was a personal series of 164 patients.

Based on series of 270 patients, the five year survival by stage was:

In a series of 16 patients, 5 (28%) showed elevated levels of CA 125.

A 2007 article describes similar improvement in a series of 11 patients.

Kato et al. have reported on a series of 26 patients with far-advanced cancer for whom there were no further treatment options.

In a series of 12 patients the mean gestation age was 45 days.